The ADC industry is undoubtedly booming right now, following successes from Enhertu and Trodlevy. However, due to challenges in resistance, safety, cellular trafficking and payload optimization, drug developers are looking to widen their toolkit of payloads, and outsource to experts in payload development and synthesis.
The inaugural ADC Payload Summit is uniting 60+ Chemists, Medicinal Chemists, and those involved with Discovery to improve efficacy of traditional payloads, diversify mechanisms of action in toolkits of payloads and broader therapeutics applications of ADCs in cancer and beyond!
These drug developers are looking to partner with companies working in the ADC payload space who can provide them with novel payloads to utilize with their ADC, and for companies who can help them in their design and synthesis of both novel and traditional payloads.
Email sponsor@hansonwade.com to learn more.